"Eric Dillon’s shoulder pain led to a multiple myeloma diagnosis, according to CBS News, after initial misdiagnoses as a rotator cuff injury."
The Unusual Path from Shoulder Pain to Cancer Diagnosis
Eric Dillon’s journey began with what seemed like a routine shoulder injury. In May 2024, he experienced "tremendous pain" while working in his Houston yard, prompting a visit to an orthopedic doctor. Initial tests suggested a strained rotator cuff, and physical therapy provided temporary relief. However, recurring discomfort over two years went undiagnosed until a burst of severe pain led to an MRI revealing something far more serious. "I walked in, and she was like, ‘You know why you’re here?’ I was like, ‘I’ve got a referral from another doctor to see you,’" Dillon recalled. The diagnosis: multiple myeloma, a blood cancer that had been masquerading as musculoskeletal pain.
The case highlights a critical gap in medical awareness. Dr. Hearn Cho, an oncologist and chief medical officer of the Multiple Myeloma Research Foundation, explained that multiple myeloma often presents as musculoskeletal issues. "The bones of the spinal column are often involved in myeloma, and so that causes back pain. But back pain is probably the number one or number two most common complaint in general medicine," Cho said. "It can be very difficult to make the diagnosis, and can take a long time."
Understanding Shoulder Pain: Common Causes and Misdiagnoses
Shoulder pain is a pervasive issue, often stemming from overuse, injury, or degenerative conditions. According to the Cleveland Clinic, common causes include rotator cuff tears, tendonitis, and bursitis. "Night pain is the hallmark of a rotator cuff tear," said orthopaedic surgeon Mark Schickendantz, MD. "You also may have this type of injury if you feel pain when lifting your arm overhead." WebMD further detailed the complexity of the shoulder joint, noting that its mobility makes it prone to dislocation and repetitive strain injuries.
However, these conditions can overlap with more severe issues. A 2022 study in BMC Musculoskeletal Disorders found that the shoulder’s vulnerability to misdiagnosis stems from its intricate anatomy. "Because the shoulder is the body’s most mobile joint, it is uniquely vulnerable when bones, tendons, and bursae lose coordination," the study noted. This complexity may explain why Dillon’s pain was initially attributed to a musculoskeletal issue rather than a systemic illness.
The Disproportionate Impact of Multiple Myeloma on Black Patients
Dillon’s diagnosis also underscores a troubling racial disparity. Dr. Cho emphasized that Black Americans are disproportionately affected by multiple myeloma. "Even though Black people are about 4% of the U.S. population, they’re about 20% of multiple myeloma patients," he said. Black patients also tend to develop the disease at an earlier age, a trend echoed in recent research.
This disparity raises questions about access to care and genetic factors. A 2024 analysis in The New England Journal of Medicine linked higher prevalence among Black individuals to both socioeconomic barriers and biological differences, though the exact mechanisms remain under study. "Being in a clinical trial, to me, was a plus," Dillon said. "It gave me a little more control and more understanding of what was going on." His participation in a trial reflects broader efforts to address underrepresentation in medical research.
The Role of Clinical Trials in Multiple Myeloma Treatment
Clinical trials play a pivotal role in advancing treatment for multiple myeloma. Dillon’s decision to join a trial was driven by both personal and altruistic motives. "I wanted to do what I could to make clinical trials more equitable," he said. Dr. Cho noted that Black patients are historically underrepresented in such studies, despite the disease’s higher prevalence in their communities.
The benefits of trials extend beyond individual patients. "Clinical trials are essential for developing new therapies and improving outcomes," said a 2024 report in The Lancet Oncology. For Dillon, the trial provided a treatment plan that stabilized his condition. "From that point forward, everything seems to have gone well. There were no major side effects," he said.
What Comes Next for Patients Like Dillon?
The future for multiple myeloma patients hinges on early detection and equitable access to care. While advancements in treatment have improved survival rates, challenges remain. "It was just tremendous to be pain-free and moving forward," Dillon said, reflecting on his recovery. His story underscores the importance of raising awareness about the disease’s subtle warning signs.
For readers, the takeaway is clear: persistent shoulder pain should not be dismissed as a minor issue. "If you have severe shoulder pain that gets worse or lasts more than a couple of days, you may have an injury to your shoulder or an underlying condition," advised the Cleveland Clinic. For those with risk factors, including Black individuals, proactive medical evaluation is critical.
As research continues to unravel the complexities of multiple myeloma, stories like Dillon’s remind us of the human cost of delayed diagnosis. "Now, everything is beautiful," he said, a testament to resilience and the power of timely intervention.
"Eric Dillon’s experience highlights the importance of recognizing atypical symptoms of serious conditions," according to the Cleveland Clinic. "Seeking timely medical evaluation can make all the difference."
"Dr. Hearn Cho, chief medical officer of the Multiple Myeloma Research Foundation."
"According to BMC Musculoskeletal Disorders."
"According to The New England Journal of Medicine."
"According to The Lancet Oncology."
"Eric Eric Dillon's experience highlights the importance of recognizing atypical symptoms of serious conditions, such as shoulder pain, which can be a warning sign of more serious underlying issues if left untreated or without proper medical attention.
Find more reporting in our Health section.
